Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: An observational multicentre study
Savulescu, C., Krizova, P., Lepoutre, A., Mereckiene, J., Vestrheim, D.F., Ciruela, P., Ordobas, M., Guevara, M., McDonald, E., Morfeldt, E., Kozakova, J., Varon, E., Cotter, S., Winje, B.A., Munoz-Almagro, C., Garcia, L., Castilla, J., Smith, A., Henriques-Normark, B., Celentano, L.P., Hanquet, G.
Rapid Risk Assessment: Cyclovirus in cerebrospinal fluid of patients with central nervous system infection
This assessment is related to the publication of the identification of a new cyclovirus species, tentatively named cyclovirus-Vietnam (CyCV-VN), in cerebrospinal fluid of patients with acute central nervous system infection. However, there are insufficient data to assess the risk for disease occurrence in humans or potential of human-to-human transmission. Further studies should be encouraged in Europe and elsewhere to investigate the possible pathogenicity, epidemiology, and transmission patterns of cycloviruses.
Rapid risk assessment: Review of the epidemiological situation of West Nile virus infection in the European Union
In the ongoing 2011 West Nile virus transmission season, cases have been reported from newly affected geographical areas
Strategies for disease-specific programmes 2010–2013
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the European Union (EU) level.